InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ststephensrevenge post# 162959

Tuesday, 02/25/2014 6:08:40 PM

Tuesday, February 25, 2014 6:08:40 PM

Post# of 346071
Peregrine never spent and took a write down of $2.5 Billion dollars such as BMS.... heck, they have done everything on less than 20% of that mistake that BMS made, and will see 10x the earnings that BMS expected from that purchase. Actually.... thats part of the reason that Elliot Sigal probably left as well..... that and who knows what more : )

Glory Days ahead... : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News